Catalogo dei prodotti della ricerca

ATTILI, Adolfo Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.559
EU - Europa 5.528
AS - Asia 1.875
AF - Africa 211
SA - Sud America 93
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 22.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.368
IT - Italia 2.966
IN - India 779
SE - Svezia 662
SG - Singapore 530
CN - Cina 522
FI - Finlandia 502
DE - Germania 458
UA - Ucraina 416
GB - Regno Unito 155
BJ - Benin 137
CA - Canada 114
IE - Irlanda 113
AR - Argentina 72
BG - Bulgaria 70
BZ - Belize 64
TG - Togo 60
FR - Francia 41
AT - Austria 37
RO - Romania 22
BE - Belgio 20
IR - Iran 18
NL - Olanda 17
RU - Federazione Russa 14
MX - Messico 13
CH - Svizzera 12
BR - Brasile 11
SC - Seychelles 6
ZA - Sudafrica 6
VE - Venezuela 5
CL - Cile 4
ES - Italia 4
ID - Indonesia 4
PL - Polonia 4
PT - Portogallo 4
TR - Turchia 4
EU - Europa 3
HK - Hong Kong 3
KR - Corea 3
NZ - Nuova Zelanda 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
JP - Giappone 2
MY - Malesia 2
NO - Norvegia 2
VN - Vietnam 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
JO - Giordania 1
NG - Nigeria 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 22.272
Salva come PNG Salva come JPEG
Città #
Fairfield 2.332
Woodbridge 1.127
Ashburn 1.073
Chandler 983
Seattle 889
Houston 842
Cambridge 770
Wilmington 752
Ann Arbor 650
Princeton 540
Rome 511
Dearborn 420
Plano 408
San Paolo di Civitate 364
Beijing 288
Singapore 256
Millbury 237
Lawrence 211
Jacksonville 176
San Diego 166
San Jose 157
Des Moines 146
Frankfurt am Main 144
Fasano 137
Boston 134
Fremont 133
Milan 129
Bremen 115
Dublin 112
Helsinki 99
San Mateo 97
Andover 95
Norwalk 84
Dallas 75
Boardman 73
Federal 72
Florence 66
Belize City 64
Sofia 64
Lomé 60
Palermo 59
Ottawa 55
Southend 54
Toronto 51
Falls Church 50
Turin 49
Naples 44
Saint Louis 39
Vienna 36
Los Angeles 35
Bühl 33
Hefei 31
Pisa 31
Catania 28
Auburn Hills 27
Bologna 26
Columbus 25
Kunming 25
New York 25
Chicago 23
Lucca 23
Washington 22
Bari 20
Brussels 20
Nanjing 20
Atlanta 19
Genoa 19
Nanchang 18
Livorno 17
Mannheim 17
Perugia 17
Brescia 16
Jinan 16
Cagliari 12
Guangzhou 12
Formigine 11
Indiana 11
London 11
Buffalo 10
Leawood 10
Padova 10
Torino 10
Bern 9
Hebei 9
Pescara 9
Reggio Emilia 9
Salerno 9
Altopascio 8
Empoli 8
Grafing 8
Mexico City 8
Mumbai 8
Napoli 8
Verona 8
Arezzo 7
Fuzhou 7
Latina 7
Cascina 6
Foggia 6
Genzano Di Roma 6
Totale 16.278
Salva come PNG Salva come JPEG
Nome #
Ridotta prevalenza di “skip areas” nel fegato steatosico in pazienti con calcolosi multipla della colecisti ed in soggetti colecistectomizzati 2.160
Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial. 123
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 115
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis 110
High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study 103
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 102
Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial 102
A new highly effective short-term therapy schedule for Helicobacter pylori eradication. 101
Donor/recipient body surface area ratio as a novel predictor of graft survival after deceased donor liver transplantation 98
Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: A pilot study 98
Relationship between antral lymphocyte density and basal gastrin levels in patients with Helicobacter pylori infection. 96
BACTERIAL INFECTIONS AND SEPSIS ACUTELY DETERIORATE LIVER FUNCTION IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY 96
Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control 95
Intraoperative histological ischemia–reperfusion injury assessment but not clinical early allograft dysfunction predicts graft loss only in HCV positive recipients submitted to liver transplant 95
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 93
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation 93
Inhibition of biliary bicarbonate secretion in ethinyl estradiol-induced cholestasis is not associated with impaired activity of the Cl-/HCO3- exchanger in the rat. 92
Cirrhotic patients are at risk for health care-associated bacterial infections. 92
Estrogens and Igf1 promote the proliferation of hepatic cyst epithelium in autosomal dominant polycystic kidney disease (ADPKD) 92
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 89
Long-term effect of liver transplantation on cirrhotic autonomic cardiac dysfunction 88
Chronic renal dysfunction after liver transplantation: Incidence and risk factors 88
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 88
Does nutritional status influence the outcome in patients undergoing liver transplantation in the “MELD” era? 88
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: A randomized prospective study 87
DONOR/RECIPIENT BODY SURFACE AREA RATIO AS A NOVEL PREDICTOR OF GRAFT SURVIVAL AFTER DECEASED DONOR LIVER TRANSPLANTATION 87
Helicobacter pylori urease inhibition and ammonia levels in cirrhotic patients 86
Acute alcoholic hepatitis 85
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 85
The management of failed dual or triple therapy for Helicobacter pylori eradication 85
Zinc, ammonia, and Helicobacter pylori infection in liver cirrhosis. 84
The activation of IGF1 system is a requisite for cholangiocyte survival during the progression of primary biliary cirrhosis (PBC) 83
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis. 83
Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage 82
ANTIVIRAL TREATMENT MAY IMPROVE THE OUTCOME OF PATIENTS WITH RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 82
Management and outcomes of hepatic cirrhosis: Findings from the RING study 81
Outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma 81
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 81
Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report 80
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 80
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (tips): PTFE-covered stent grafts versus bare stents 80
OLDER DONOR AGE IS ASSOCIATED WITH INCREASED DONOR OXIDATIVE STRESS AND FAILURE TO RESTORE BASAL PROTEIN GRAFT CONTENT AFTER ISCHEMIA REPERFUSION IN HUMAN LIVER TRANSPLANTATION 79
Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. 79
EFFECT OF RIBAVIRIN PRE-TREATMENT ON EARLY VIROLOGICAL RESPONSE OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 79
Differential VEGF-A protein expression between small HCC and cirrhosis at distance from the tumor correlates with serum VEGF-A and alpha-fetoprotein 79
Reflux oesophagitis after Helicobacter pylori treatment 79
Helicobacter pylori eradication with proton pump inhibitor – based triple therapies and re – treatment with ranitidine bismuth citrate – based triple therapy 78
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation 78
Progression of low risk esophageal varices in cirrhotic patients 78
Role of the determination of partial pressure of ammonia in cirrhotic patients with hepatic encephalopathy 78
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 78
ACOUSTIC RADIATION FORCE IMPULSE ELASTOGRAPHY" (ARFI) ASSESSMENT OF FOCAL NODULAR HYPERPLASIA: PRELIMINARY RESULTS 78
Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity 77
Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis 76
One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation 76
Estrogens and IGF1 promote the proliferation of hepatic cyst epithelium in autosomal dominant polycystic kidney disease (ADPKD) 76
COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN (HBIG) AND LAMIVUDINE (LAM) IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE: LONG TERM EFFICACY AND COSTS 76
PREDICTIVE RISK FACTORS OF RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION 76
MELD, PROTEIN MALNUTRITION AND PREVIOUS INFECTIONS ARE PREDICTORS OF BACTERIAL INFECTIONS AND SEPSIS IN CIRRHOTIC PATIENTS 76
Natural history of low risk esophageal varices in cirrhotic patients 75
Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results 75
Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat 74
DONOR/RECIPIENT BODY SURFACE AREA RATIO AS A NOVEL PREDICTOR OF GRAFT SURVIVAL AFTER DECEASED DONOR LIVER TRANSPLANTATION 74
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis 74
Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation 74
Nutritional status: its influence on the outcome of patients undergoing liver transplantation 74
Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C 74
PTFE-covered stent-grafts for tips procedure: One-year patency and clinical results 74
Alfa and beta estrogen receptors and the biliary tree 74
A comparison of cell blood analyzer and manual hemacytometer for polymorphonuclear cell count in the ascttic fluid in cirrhotic patients with and without spontaneous bacterial peritonitis 73
Helicobacter pylori density and cagA status in cirrhotic patients: a case-control study. 73
Clinical Manifestations of gallstone disease: evidence from the Multicenter Italian study on Cholelithiasis (MICOL) 72
RECIPIENT MTHFR C677T POLYMORPHISM PREDICTS PRE-TRANSPLANT CIRRHOSIS PROGRESSION AND SURVIVAL AFTER LIVER TRANSPLANTATION 72
The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis 72
Epidemiology and association with extra-gastrointestinal diseases 71
Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. 71
Older donor age is associated with increased donor oxidative stress and failure to restore basal total protein graft content after ischemia reperfusion injury in human liver transplantation 71
Predictors of outcome of liver transplantation in patients with liver cirrhosis and hepatocellular carcinoma 71
Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation 71
Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis. 71
Estrogens and IGF1 promote the proliferation of hepatic cyst epithelium in autosomal dominant polycystic kidney disease (ADPKD) 70
Hepatic steatosis after liver transplantation: Prevalence and associated factors 70
Early hepatocyte C4d expression and failure to restore basal hepatic total protein content after ischaemia–reperfusion are associated with 1-year graft loss in human liver transplantation 70
Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis 69
Bone density and nutritional assessment in cirrhotic patients 69
An improved gas-chromatographic method for the determination of sulfated and unsulfated bile acids in serum 69
ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION 69
ARFI Elastometry Assessment of Focal Nodular Hyperplasia: Preliminary Results 69
CHANGES IN BODY COMPOSITION IN THE FIRST MONTHS AFTER LIVER TRANSPLANTATION 69
Expression of estrogen receptors in cholangiocytes of patients with primary biliary cirrhosis (PBC) and relationship with immunohistochemical markers of cell proliferation and death 68
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS): PTFE-covered stent-grafts versus bare stents 68
Transjugular intrahepatic portosystemic shunt (TIPS) is feasible in non-cirrhotic patients with cavernomatous tranformation of the portal vein 67
Early postprandial energy expenditure and macronutrient use after a mixed meal in cirrhotic patients. 67
A new 10-day regimen for Helicobacter pylori (HP) eradication 67
Short-term changes in nutritional status, energy expenditure, dietary intake in patients undergoing liver transplantation 67
RECIPIENT MTHFR C677T POLYMORPHISM PREDICTS PRE-TRANSPLANT CIRRHOSIS PROGRESSION AND SURVIVAL AFTER LIVER TRANSPLANTATION 67
Helicobacter pylori diagnosis in patients with liver cirrhosis 67
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 67
Kinetic characterisation in needle biopsies of hepatocellular carcinama: feasibility and preliminari results. 66
MELD, PROTEIN MALNUTRITION AND PREVIOUS INFECTIONS ARE PREDICTORS OF BACTERIAL INFECTIONS AND SEPSIS IN CIRRHOTIC PATIENTS 66
Totale 10.096
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.736 747 194 48 226 482 1.496 739 577 541 344 210 132
2020/20211.508 163 217 50 172 30 104 25 211 131 159 81 165
2021/20224.145 24 207 404 105 603 97 64 461 440 362 488 890
2022/20234.879 908 856 265 679 448 490 154 248 427 125 173 106
2023/20242.280 160 271 159 157 212 258 125 155 35 311 196 241
2024/2025202 202 0 0 0 0 0 0 0 0 0 0 0
Totale 22.697